Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02695771 · ClinicalTrials.gov registry record · Phase 3
The Bladder Instillation Comparison Study
A Phase 3 study, sponsored by Corewell Health West.
- Completed
- Registry status
- Phase 3
- Development phase
- 101
- Enrollment target
NCT02695771 is a Phase 3 study that has completed, run by Corewell Health West. The registered enrollment target is 101 participants.
The verdict
NCT02695771, a Phase 3 study, has completed, sponsored by Corewell Health West.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 101 participants
- Enrollment target
Study Summary
To compare the efficacy of Mitomycin C vs. Gemcitabine vs. no adjuvant treatment as a single intraoperative instillation in preventing recurrence of bladder cancer.
Interventions
- DRUG Gemcitabine
- DRUG Mitomycin C
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2016-04-19 |
| Est. Completion | 2021-10-22 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02695771
The ClinicalTrials.gov registry entry for NCT02695771 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health West, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Gemcitabine is the first listed.
NCT02695771 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02695771 about?
NCT02695771 is a clinical study titled "The Bladder Instillation Comparison Study". To compare the efficacy of Mitomycin C vs. Gemcitabine vs. no adjuvant treatment as a single intraoperative instillation in preventing recurrence of bladder cancer.
What is the current status of trial NCT02695771?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 101 participants. The study started on 2016-04-19. Estimated completion is 2021-10-22.
What interventions are being tested in trial NCT02695771?
The interventions under investigation include: Gemcitabine (DRUG), Mitomycin C (DRUG).
Who is sponsoring clinical trial NCT02695771?
This trial is sponsored by Corewell Health West, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.